| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |